Application of Gold Nanoparticles as Radiosensitizer for Metastatic Prostate Cancer Cell Lines
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24044122 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Sílvia Soares und 8 weiteren Autor:innen. Beteiligte Einrichtung: ICBAS-School of Medicine and Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal. Hauptthemen laut MEDLINE: Metal Nanoparticles, Radiation-Sensitizing Agents, Prostatic Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Science and Technology.
Abstract (Originalsprache)
More than 50% of all prostate cancer (PCa) patients are treated by radiotherapy (RT). Radioresistance and cancer recurrence are two consequences of the therapy and are related to dose heterogeneity and non-selectivity between normal and tumoral cells. Gold nanoparticles (AuNPs) could be used as potential radiosensitizers to overcome these therapeutic limitations of RT. This study assessed the biological interaction of different morphologies of AuNPs with ionizing radiation (IR) in PCa cells. To achieve that aim, three different amine-pegylated AuNPs were synthesized with distinct sizes and shapes (spherical, AuNPsp-PEG, star, AuNPst-PEG, and rods, AuNPr-PEG) and viability, injury and colony assays were used to analyze their biological effect on PCa cells (PC3, DU145, and LNCaP) when submitted to the accumulative fraction of RT. The combinatory effect of AuNPs with IR decreased cell viability and increased apoptosis compared to cells treated only with IR or untreated cells. Additionally, our results showed an increase in the sensitization enhancement ratio by cells treated with AuNPs and IR, and this effect is cell line dependent. Our findings support that the design of AuNPs modulated their cellular behavior and suggested that AuNPs could improve the RT efficacy in PCa cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ICBAS-School of Medicine and Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal.
- FP-I3ID, FP-BHS, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal.
- Instituto de Investigação e Inovação em Saúde (i3S), 4200-135 Porto, Portugal.
- Faculty of Chemistry, University of Vigo, 36310 Vigo, Spain.
- CEB, Centre of Biological Engineering of Minho University, 4710-057 Braga, Portugal.
- BioMark@ISEP/CEB-Center of Biological Engineering of Minho University, School of Engineering, Polytechnic Institute of Porto, 4249-015 Porto, Portugal.
ORCID-Profile: Sílvia Soares, Isabel Faria, Fátima Aires, Maria Goreti Sales, Miguel A Correa-Duarte, Susana G Guerreiro, Rúben Fernandes
Förderung
- Foundation for Science and Technology
Zitieren
APA
Soares, S., Faria, I., Aires, F., Monteiro, A., Pinto, G., Sales, M. G., Correa-Duarte, M. A., Guerreiro, S. G., & Fernandes, R. (2023). Application of Gold Nanoparticles as Radiosensitizer for Metastatic Prostate Cancer Cell Lines. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24044122
Vancouver
Soares S, Faria I, Aires F, Monteiro A, Pinto G, Sales MG, et al. Application of Gold Nanoparticles as Radiosensitizer for Metastatic Prostate Cancer Cell Lines. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24044122
BibTeX
@article{Soares2023,
author = {Soares, Sílvia and Faria, Isabel and Aires, Fátima and Monteiro, Armanda and Pinto, Gabriela and Sales, Maria Goreti and Correa-Duarte, Miguel A and Guerreiro, Susana G and Fernandes, Rúben},
title = {Application of Gold Nanoparticles as Radiosensitizer for Metastatic Prostate Cancer Cell Lines},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24044122}
}
EUVIMED